ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

Deparle Leaves HCFA; Speyer Promoted At NYU Center.

September 15, 2000

QOL Of Young Survivors Equal To Other Children

February 25, 2005

Caution Advised for Hormone Replacement Therapy

March 21, 1986

NIH Seeks Comment On Reorg Plan For Oncology Study Sections

April 5, 2002

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014